Who likely does not need it: Young people with no cardiovascular risk factors and normal baseline lipids
Similarly, those switching from Zepbound to orforglipron experienced a 2.6 kg gain versus a 9.1 kg gain for placebo
Next, non-GMO labeling indicates that hens were fed a diet that did not contain GMO ingredients
He serves as a site principal investigator for two federally funded clinical trials (NIH STABILITY 2 and Department of Defense STaR Trial)
By harnessing the power of a GLP-1, GIP, and glucagon receptor agonist simultaneously, this medication is being studied for effects on appetite, metabolic signaling, and energy balance
After starting GLP-1s, these patients experienced higher rates of dizziness, fainting and other events related to low blood pressure, also known as hypotension